S&P 5007,736.52▲1.8% Nasdaq26,584.99▲2.6% Dow54,085.88▲1.7% Russell 2K3,036.98▲1.9% 10-Yr4.63%−6bp VIX16.50+0.64 WTI$75.32▼6.2% Gold$4,133.60▲2.5% EUR/USD1.153▼0.1% BTC$64,898▲1.3% Nikkei63,755▼0.9%
At close · Tue, Aug 4, 2026
Daily Market Updates.

Earnings

Home›Earnings›Previews›Eli Lilly price target raised after beat-and-raise qua…

Eli Lilly price target raised after beat-and-raise quarter

CNBC Earnings said strength in the company’s GLP-1 business indicates the stock may have further upside.

Reported · Written up by our desk · Previews

Eli Lilly’s stock price target was increased following another beat-and-raise quarter, according to CNBC Earnings.

The outlet pointed to ongoing strength in the company’s GLP-1 business, arguing it suggests the shares still have more room to run.

The update frames the latest results as confirmation of momentum in Eli Lilly’s GLP-1 franchise.

← Newer storyTreasuries hold steady after ISM impact, fuel prices steady

More like this

EarningsSpaceX revenue jumps 92% year over year as cash burn remains a risk
EarningsSandisk slips slightly ahead of fiscal fourth-quarter earnings
EarningsAMD shares slide after beat-and-raise as AI product deliveries near
EarningsTanger links summer traffic and sales to World Cup
EarningsHims & Hers rallies as FTC suit targets privacy and data sharing

Sources

CNBC EarningsWe're increasing our Eli Lilly price target after another beat-and-raise quarter

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.